Abstract
WE recently reported that PGE1 and isoprenaline have very different effects on the substrates of cyclic AMP-dependent protein kinase that regulate cardiac glycogen metabolism. Both agents elevated the cyclic" AMP content and the protein kinase activity ratio in isolated perfused rat hearts, but only isoprenaline caused changes in the activity of the substrates of protein kinase (presumably phosphorylation, causing activation of phosphorylase kinase and inactivation of glycogen synthase)1,2. Thus, the activation of soluble protein kinase appears insufficient to a cause alteration of the regulatory enzymes of glycogen metabolism. This suggests that the gly-cogenolytic responses to isoprenaline involve actions other than the activation of soluble protein kinase. We now report the effects of PGE1 and isoprenaline on another substrate of protein kinase, the inhibitory subunit of cardiac troponin (TNI). Since the phosphorylation of TNI may mediate the positive inotropic effects associated with β-adrenergic stimulation and cyclic AMP accumulation3, we felt that the hormonally specific expression of protein kinase activity might be used as a tool to determine whether similar specificity applies to the phosphorylation of TNI and to establish the functional relevance of that phosphorylation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reese, J. B., Hayes, J. S., Brunton, L. L., Brown, J. H. & Mayer, S. E. Pharmacologist 20, 232 (1978).
Hayes, J. S., Brunton, L. L., Brown, J. H., Reese, J. B. & Mayer, S. E. Proc. natn. Acad. Sci. U.S.A. 76, 1570–1574 (1979).
England, P. Biochem. J. 160, 295–304 (1976).
Stull, J. T. & Buss, J. E. J. biol. Chem. 252, 851–857 (1977).
Stull, J. T., Blumenthal, D. K., de Lanerolle, P., High, C. W. & Manning, D. R. Adv. Pharmac. Therapeutics 3, 171–180 (1978).
England, P. J. Biochem. J. 168, 307–310 (1977).
Cole, H. A. & Perry, S. V. Biochem. J. 149, 525–533 (1975).
Moir, A. J. G. & Perry, S. V. Biochem. J. 167, 333–343 (1977).
Ezrailson, E. G., Potter, J. D., Michael, L. & Schwartz, A. J. molec. cell. Cardiol. 9, 693–698 (1977).
Frearson, N., Solaro, R. J. & Perry, S. V. Nature 264, 801–802 (1976).
Keely, S. L. Molec. Pharm. 15, 235–245 (1979).
Corbin, J. D., Sugden, P. H., Lincoln, T. M. & Keely, S. L. J. biol. Chem. 252, 3854–3861 (1977).
Russell, D. H. Adv. Cyclic Nucleotide Res. 9, 493–506 (1978).
Terasaki, W. L. & Brooker, G. J. biol. Chem. 252, 1041–1050 (1977).
Parker, C. W. Adv. Cyclic Nucleotide Res. 9, 647–660 (1978).
Hayes, J. S., Brunton, L. L. & Mayer, S. E. (in preparation).
Neely, J. R. & Rovetto, M. J. Meth. Enzym. 39, 43–59 (1975).
Gilman, A.G. Proc. natn. Acad. Sci. U.S.A. 67, 305–312 (1970).
Keely, S. L., Corbin, J. D. & Park, C. R. J. biol. Chem. 250, 4832–4840 (1975).
Hardman, J. G., Mayer, S. E. & Clark, B. J. Pharmac. exp. Ther. 150, 341–348 (1965).
Syska, M., Perry, S. V. & Trayer, I. P. FEBS Lett. 40, 253–257 (1974).
Kleinsmith, L. J., Allfrey, V. G. & Mirsky, A. E. Proc. natn. Acad. Sci. U.S.A. 55, 1182–1189 (1966).
Itaya, K. & Ui, M. Clin. chim. Acta. 14, 361–366 (1966).
Ames, B. N. Meth. Enzym. 8, 116–118 (1966).
Bradford, M. M. Analyt. Biochem. 72, 248–254 (1976).
Grand, R. J. A., Wilkinson, J. M., Mole, L. E. Biochem. J. 159, 633–641 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BRUNTON, L., HAYES, J. & MAYER, S. Hormonally specific phosphorylation of cardiac troponin I and activation of glycogen phosphorylase. Nature 280, 78–80 (1979). https://doi.org/10.1038/280078a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/280078a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.